Naturally occurring variant of mouse apolipoprotein A-I alters the lipid and HDL association properties of the protein

Journal of Lipid Research

Volumn 53, Issue 5, 2012, Pages 951-963

  Sontag, Timothy J ^a   Carnemolla, Ronald ^b   Vaisar, Tomas ^c   Reardon, Catherine A ^a   Getz, Godfrey S ^a  

^a UNIVERSITY OF CHICAGO   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Alpha helix; Cholesterol efflux; High density lipoprotein; Lipid binding

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN A2; HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; PHOSPHATIDYLCHOLINE STEROL ACYLTRANSFERASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATHEROSCLEROSIS; BINDING AFFINITY; CARBOXY TERMINAL SEQUENCE; CATABOLISM; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL TRANSPORT; CONTROLLED STUDY; DISEASE PREDISPOSITION; ENZYME ACTIVATION; FEMALE; GENETIC POLYMORPHISM; IN VIVO STUDY; LIVER CELL; MICELLE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; PROTEIN LIPID INTERACTION; PROTEIN METABOLISM; PROTEIN PROTEIN INTERACTION; PROTEIN SYNTHESIS;

ANIMALS; APOLIPOPROTEIN A-I; BIOLOGICAL TRANSPORT; CELL LINE; CHOLESTEROL, HDL; ENZYME ACTIVATION; FEMALE; HUMANS; LIVER; MICE; PHOSPHATIDYLCHOLINE-STEROL O-ACYLTRANSFERASE; POLYMORPHISM, GENETIC;

EID: 84860290524     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.M021154     Document Type: Article

References (48)

1. Thom, T., N. Haase, W. Rosamond, V. J. Howard, J. Rumsfeld, T. Manolio, Z-J. Zheng, K. Flegal, C. O'Donnell, S. Kittner, et al. 2006. Heart disease and stroke statistics-2006 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 113: e85-e151.
2. Perper, J. A., L. H. Kuller, and M. Cooper. 1975. Arteriosclerosis of coronary arteries in sudden, unexpected deaths. Circulation. 52: III27-III33.
3. Boden, W. E. 2000. High-density lipoprotein cholesterol as an independent risk factor in cardiovascular disease: assessing the data from Framingham to the Veterans Affairs High Density Lipoprotein Intervention Trial. Am. J. Cardiol. 86: 19L-22L.
4. Paigen, B., A. Morrow, C. Brandon, D. Mitchell, and P. Holmes. 1985. Variation in susceptibility to atherosclerosis among inbred strains of mice. Atherosclerosis. 57: 65-73. (Pubitemid 15247039)
5. Dansky, H. M., S. A. Charlton, J. L. Sikes, S. C. Heath, R. Simantov, L. F. Levin, P. Shu, K. J. Moore, J. L. Breslow, and J. D. Smith. 1999. Genetic background determines the extent of atherosclerosis in ApoE-deficient mice. Arterioscler. Thromb. Vasc. Biol. 19: 1960-1968. (Pubitemid 29379929)
6. Teupser, D., A. D. Persky, and J. L. Breslow. 2003. Induction of atherosclerosis by low-fat, semisynthetic diets in LDL receptordefi cient C57BL/6J and FVB/NJ mice: comparison of lesions of the aortic root, brachiocephalic artery, and whole aorta (en face measurement). Arterioscler. Thromb. Vasc. Biol. 23: 1907-1913. (Pubitemid 37254883)
7. Svenson, K. L., R. Von Smith, P. A. Magnani, H. R. Suetin, B. Paigen, J. K. Naggert, R. Li, G. A. Churchill, and L. L. Peters. 2007. Multiple trait measurements in 43 inbred mouse strains capture the phenotypic diversity characteristic of human populations. J. Appl. Physiol. 102: 2369-2378. (Pubitemid 47080772)
8. Schultz, J. R., J. G. Verstuyft, E. L. Gong, A. V. Nichols, and E. M. Rubin. 1993. Protein composition determines the anti-atherogenic properties of HDL in transgenic mice. Nature. 365: 762-764. (Pubitemid 23339884)
9. Puppione, D. L., L. M. Yam, S. Bassilian, P. Souda, L. W. Castellani, V. N. Schumaker, and J. P. Whitelegge. 2006. Mass spectral analysis of the apolipoproteins on mouse high density lipoproteins. Detection of post-translational modifications. Biochim. Biophys. Acta. 1764: 1363-1371. (Pubitemid 44279565)
10. Strausberg, R. L., E. A. Feingold, L. H. Grouse, J. G. Derge, R. D. Klausner, F. S. Collins, L. Wagner, C. M. Shenmen, G. D. Schuler, S. F. Altschul, et al. 2002. Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences. Proc. Natl. Acad. Sci. USA. 99: 16899-16903. (Pubitemid 36034070)
11. Plump, A. S., N. Azrolan, H. Odaka, L. Wu, X. Jiang, A. Tall, S. Eisenberg, and J. L. Breslow. 1997. ApoA-I knockout mice: characterization of HDL metabolism in homozygotes and identification of a post-RNA mechanism of apoA-I up-regulation in heterozygotes. J. Lipid Res. 38: 1033-1047. (Pubitemid 27255211)
12. Zannis, V. I., A. Chroni, and M. Krieger. 2006. Role of apoA-I, ABCA1, LCAT, and SR-BI in the biogenesis of HDL. J. Mol. Med. 84: 276-294.
13. Natarajan, P., T. M. Forte, B. Chu, M. C. Phillips, J. F. Oram, and J. K. Bielicki. 2004. Identification of an apolipoprotein A-I structural element that mediates cellular cholesterol efflux and stabilizes ATP binding cassette transporter A1. J. Biol. Chem. 279: 24044-24052. (Pubitemid 38725263)
14. Panagotopulos, S. E., S. R. Witting, E. M. Horace, D. Y. Hui, J. N. Maiorano, and W. S. Davidson. 2002. The role of apolipoprotein A-I helix 10 in apolipoprotein-mediated cholesterol efflux via the ATP-binding cassette transporter ABCA1. J. Biol. Chem. 277: 39477-39484. (Pubitemid 35190924)
15. Kono, M., T. Tanaka, M. Tanaka, C. Vedhachalam, P. S. Chetty, D. Nguyen, P. Dhanasekaran, S. Lund-Katz, M. C. Phillips, and H. Saito. 2010. Disruption of the C-terminal helix by single amino acid deletion is directly responsible for impaired cholesterol efflux ability of apolipoprotein A-I Nichinan. J. Lipid Res. 51: 809-818.
16. Saito, H., P. Dhanasekaran, D. Nguyen, P. Holvoet, S. Lund-Katz, and M. C. Phillips. 2003. Domain structure and lipid interaction in human apolipoproteins A-I and E, a general model. J. Biol. Chem. 278: 23227-23232. (Pubitemid 36830135)
17. Ajees, A. A., G. M. Anantharamaiah, V. K. Mishra, M. M. Hussain, and H. M. K. Murthy. 2006. Crystal structure of human apolipoprotein A-I: insights into its protective effect against cardiovascular diseases. Proc. Natl. Acad. Sci. USA. 103: 2126-2131. (Pubitemid 43271634)
18. Tanaka, M., M. Koyama, P. Dhanasekaran, D. Nguyen, M. Nickel, S. Lund-Katz, H. Saito, and M. C. Phillips. 2008. Influence of tertiary structure domain properties on the functionality of apolipoprotein A-I. Biochemistry. 47: 2172-2180. (Pubitemid 351287143)
19. Koyama, M., M. Tanaka, P. Dhanasekaran, S. Lund-Katz, M. C. Phillips, and H. Saito. 2009. Interaction between the N- and C-terminal domains modulates the stability and lipid binding of apolipoprotein A-I. Biochemistry. 48: 2529-2537.
20. Vedhachalam, C., P. S. Chetty, M. Nickel, P. Dhanasekaran, S. Lund-Katz, G. H. Rothblat, and M. C. Phillips. 2010. Influence of apolipoprotein (Apo) A-I structure on nascent high density lipoprotein (HDL) particle size distribution. J. Biol. Chem. 285: 31965-31973.
21. Reardon, C. A., L. Blachowicz, T. White, V. Cabana, Y. Wang, J. Lukens, J. Bluestone, and G. S. Getz. 2001. Effect of immune deficiency on lipoproteins and atherosclerosis in male apolipoprotein E-deficient mice. Arterioscler. Thromb. Vasc. Biol. 21: 1011-1016. (Pubitemid 34168661)
22. Vaisar, T., S. Pennathur, P. S. Green, S. A. Gharib, A. N. Hoofnagle, M. C. Cheung, J. Byun, S. Vuletic, S. Kassim, P. Singh, et al. 2007. Shotgun proteomics implicates protease inhibition and complement activation in the antiinflammatory properties of HDL. J. Clin. Invest. 117: 746-756. (Pubitemid 46348533)
23. Kersey, P. J., J. Duarte, A. Williams, Y. Karavidopoulou, E. Birney, and R. Apweiler. 2004. The International Protein Index: an integrated database for proteomics experiments. Proteomics. 4: 1985-1988. (Pubitemid 38880363)
24. Yates, J. R., J. K. Eng, A. L. McCormack, and D. Schieltz. 1995. Method to correlate tandem mass spectra of modified peptides to amino acid sequences in the protein database. Anal. Chem. 67: 1426-1436.
25. Keller, A., A. I. Nesvizhskii, E. Kolker, and R. Aebersold. 2002. Empirical statistical model to estimate the accuracy of peptide identifications made by MS/MS and database search. Anal. Chem. 74: 5383-5392. (Pubitemid 35215372)
26. Nesvizhskii, A. I., A. Keller, E. Kolker, and R. Aebersold. 2003. A statistical model for identifying proteins by tandem mass spectrometry. Anal. Chem. 75: 4646-4658. (Pubitemid 37082259)
27. Liu, H., R. G. Sadygov, and J. R. Yates. 2004. A model for random sampling and estimation of relative protein abundance in shotgun proteomics. Anal. Chem. 76: 4193-4201. (Pubitemid 38943698)
28. Carnemolla, R., X. Ren, T. K. Biswas, S. C. Meredith, C. A. Reardon, J. Wang, and G. S. Getz. 2008. The specific amino acid sequence between helices 7 and 8 influences the binding specificity of human apolipoprotein A-I for high density lipoprotein (HDL) subclasses: a potential for HDL preferential generation. J. Biol. Chem. 283: 15779-15788.
29. Wool, G. D., C. A. Reardon, and G. S. Getz. 2008. Apolipoprotein A-I mimetic peptide helix number and helix linker influence potentially anti-atherogenic properties. J. Lipid Res. 49: 1268-1283.
30. Cabana, V. G., N. Feng, C. A. Reardon, J. Lukens, N. R. Webb, F. C. de Beer, and G. S. Getz. 2004. Influence of apoA-I and apoE on the formation of serum amyloid A-containing lipoproteins in vivo and in vitro. J. Lipid Res. 45: 317-325. (Pubitemid 38228830)
31. Doolittle, M. H., R. C. LeBoeuf, C. H. Warden, L. M. Bee, and A. J. Lusis. 1990. A polymorphism affecting apolipoprotein A-II translational efficiency determines high density lipoprotein size and composition. J. Biol. Chem. 265: 16380-16388.
32. Martinez, L. O., B. Agerholm-Larsen, N. Wang, W. Chen, and A. R. Tall. 2003. Phosphorylation of a pest sequence in ABCA1 promotes calpain degradation and is reversed by ApoA-I. J. Biol. Chem. 278: 37368-37374. (Pubitemid 37175255)
33. Wang, N., W. Chen, P. Linsel-Nitschke, L. O. Martinez, B. Agerholm-Larsen, D. L. Silver, and A. R. Tall. 2003. A PEST sequence in ABCA1 regulates degradation by calpain protease and stabilization of ABCA1 by apoA-I. J. Clin. Invest. 111: 99-107. (Pubitemid 36134853)
34. Parks, J. S., H. Li, A. K. Gebre, T. L. Smith, and N. Maeda. 1995. Effect of apolipoprotein A-I deficiency on lecithin:cholesterol acyltransferase activation in mouse plasma. J. Lipid Res. 36: 349-355.
35. Eggerman, T. L., J. M. Hoeg, M. S. Meng, A. Tombragel, D. Bojanovski, and H. B. Brewer. 1991. Differential tissue-specific expression of human apoA-I and apoA-II. J. Lipid Res. 32: 821-828.
36. Vedhachalam, C., L. Liu, M. Nickel, P. Dhanasekaran, G. M. Anantharamaiah, S. Lund-Katz, G. H. Rothblat, and M. C. Phillips. 2004. Influence of ApoA-I structure on the ABCA1-mediated efflux of cellular lipids. J. Biol. Chem. 279: 49931-49939. (Pubitemid 39577801)
37. Vedhachalam, C., A. B. Ghering, W. S. Davidson, S. Lund-Katz, G. H. Rothblat, and M. C. Phillips. 2007. ABCA1-induced cell surface binding sites for ApoA-I. Arterioscler. Thromb. Vasc. Biol. 27: 1603-1609. (Pubitemid 46986116)
38. Lusis, A. J., B. A. Taylor, R. W. Wangenstein, and R. C. LeBoeuf. 1983. Genetic control of lipid transport in mice. II. Genes controlling structure of high density lipoproteins. J. Biol. Chem. 258: 5071-5078. (Pubitemid 13096400)
39. Warden, C. H., C. C. Hedrick, J. H. Qiao, L. W. Castellani, and A. J. Lusis. 1993. Atherosclerosis in transgenic mice overexpressing apolipoprotein A-II. Science. 261: 469-472. (Pubitemid 23276555)
40. Weng, W., and J. L. Breslow. 1996. Dramatically decreased high density lipoprotein cholesterol, increased remnant clearance, and insulin hypersensitivity in apolipoprotein A-II knockout mice suggest a complex role for apolipoprotein A-II in atherosclerosis susceptibility. Proc. Natl. Acad. Sci. USA. 93: 14788-14794.
41. Hedrick, C. C., L. W. Castellani, C. H. Warden, D. L. Puppione, and A. J. Lusis. 1993. Influence of mouse apolipoprotein A-II on plasma lipoproteins in transgenic mice. J. Biol. Chem. 268: 20676-20682. (Pubitemid 23278985)
42. Gauthamadasa, K., N. S. Vaitinadin, J. L. Dressman, S. Macha, R. Homan, K. D. Greis, and R. A. G. D. Silva. 2012. Apolipoprotein A-II mediated conformational changes of apolipoprotein A-I in discoidal high density lipoproteins. J. Biol. Chem.; Epub ahead of Print.
43. Lagocki, P. A., and A. M. Scanu. 1980. In vitro modulation of the apolipoprotein composition of high density lipoprotein. Displacement of apolipoprotein A-I from high density lipoprotein by apolipoprotein A-II. J. Biol. Chem. 255: 3701-3706. (Pubitemid 10011833)
44. Rye, K-A., K. Wee, L. K. Curtiss, D. J. Bonnet, and P. J. Barter. 2003. Apolipoprotein A-II inhibits high density lipoprotein remodeling and lipid-poor apolipoprotein A-I formation. J. Biol. Chem. 278: 22530-22536. (Pubitemid 36830308)
45. Cavigiolio, G., E. G. Geier, B. Shao, J. W. Heinecke, and M. N. Oda. 2010. Exchange of apolipoprotein A-I between lipid-associated and lipid-free states: a potential target for oxidative generation of dysfunctional high density lipoproteins. J. Biol. Chem. 285: 18847-18857.
46. Khovidhunkit, W., M-S. Kim, R. A. Memon, J. K. Shigenaga, A. H. Moser, K. R. Feingold, and C. Grunfeld. 2004. Effects of infection and inflammation on lipid and lipoprotein metabolism: mechanisms and consequences to the host. J. Lipid Res. 45: 1169-1196. (Pubitemid 38802622)
47. Suzuki, M., D. K. Pritchard, L. Becker, A. N. Hoofnagle, N. Tanimura, T. K. Bammler, R. P. Beyer, R. Bumgarner, T. Vaisar, M. C. de Beer, et al. 2010. High-density lipoprotein suppresses the type I interferon response, a family of potent antiviral immuno-regulators, in macrophages challenged with lipopolysaccharide. Circulation. 122: 1919-1927.
48. Roberts, J. E., J. W. Watters, J. D. Ballard, and W. F. Dietrich. 1998. Ltx1, a mouse locus that influences the susceptibility of macrophages to cytolysis caused by intoxication with Bacillus anthracis lethal factor, maps to chromosome 11. Mol. Microbiol. 29: 581-591. (Pubitemid 28330790)